chitosan has been researched along with Hypertension in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, P; Jensen, DM; Kriegel, AJ; Liang, M; Liu, J; Lopez-Berestein, G; Mangala, LS; Sood, AK; Usa, K; Widlansky, ME | 1 |
| Bai, XB; Chen, BY; Chen, YL; Ding, QF; Dong, T; Du, LJ; Duan, SZ; Hu, B; Li, YL; Liu, T; Liu, Y; Tian, GC; Xiong, XJ; Xu, S; Zhang, WC; Zhang, XQ; Zhou, LJ | 1 |
| Lai, JY; Lue, SJ; Luo, LJ; Nguyen, DD | 1 |
| Allaert, FA | 3 |
| Gökçe, EH; Gündoğdu, E; Üstündağ-Okur, N; Yurdasiper, A | 1 |
| Hafeez, Z; Imran, M; Niaz, T | 1 |
| Jain, S; Sapra, B; Tiwary, AK | 3 |
| Baĭgarin, EK; Pogozheva, AV | 1 |
| Baek, MW; Cho, GS; Cho, JE; Dutta, NK; Kim, DJ; Lee, BH; Na, YR; Park, JH; Park, SH; Seok, SH | 1 |
| Ali, J; Ali, M; Hassan, N | 1 |
| Bansal, K; Dhawan, S; Kaushik, R; Kumria, R; Singla, AK; Sinha, VR; Wadhawan, S | 1 |
| Körner, B; Poretti, F; Rosen, T; Vorwerk, D | 1 |
| Baĭgarin, EK; Derbeneva, SA; Miagkova, MA; Pogozheva, AV; Varsanovich, EA | 1 |
| Chiang, CE; Huang, SS; Sung, SH | 1 |
2 review(s) available for chitosan and Hypertension
| Article | Year |
|---|---|
Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics.
Topics: Antihypertensive Agents; Biological Availability; Chitosan; Drug Carriers; Half-Life; Humans; Hypertension; Nanomedicine | 2017 |
Chitosan microspheres as a potential carrier for drugs.
Topics: Animals; Chitin; Chitosan; Drug Carriers; Humans; Hypertension; Infections; Microspheres; Neoplasms | 2004 |
4 trial(s) available for chitosan and Hypertension
| Article | Year |
|---|---|
Effect of NaCl + Chitosan 3% vs. NaCl on high blood pressure parameters of healthy volunteers with prehypertension.
Topics: Adult; Aged; Blood Pressure; Chitosan; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prehypertension; Sodium Chloride, Dietary | 2017 |
Double-blind, randomized, crossover, controlled clinical trial of NaCl + Chitosan 3% versus NaCl on mild or moderate high blood pressure during the diet and lifestyle improvement period before possible prescription of an antihypertensive treatment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Chitosan; Cross-Over Studies; Diet; Double-Blind Method; Drug Prescriptions; Female; Humans; Hypertension; Life Style; Male; Middle Aged; Severity of Illness Index; Sodium Chloride | 2013 |
[Influence of chitosan on clinical-biochemical rates and protein metabolism of patients with cardiovascular diseases].
Topics: Body Mass Index; Chitosan; Cholesterol; Dietary Proteins; Dietary Supplements; Humans; Hypertension; Myocardial Ischemia; Obesity; Treatment Outcome | 2008 |
[Chitosan pads vs. manual compression to control bleeding sites after transbrachial arterial catheterization in a randomized trial].
Topics: Angiography; Anticoagulants; Brachial Artery; Catheterization, Peripheral; Chitosan; Diabetes Complications; Female; Hematoma; Hemostatic Techniques; Hemostatics; Humans; Hypertension; Male; Risk Factors; Time Factors | 2005 |
12 other study(ies) available for chitosan and Hypertension
| Article | Year |
|---|---|
Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications.
Topics: Angiotensin II; Animals; Chitosan; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Fibrosis; Humans; Hypertension; Mice; Mice, Inbred Strains; Mice, Knockout, ApoE; MicroRNAs; Thiolester Hydrolases | 2022 |
Alleviate Periodontitis and Its Comorbidity Hypertension using a Nanoparticle-Embedded Functional Hydrogel System.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chitosan; Comorbidity; Hydrogels; Hypertension; Mice; Nanoparticles; Periodontitis | 2023 |
The role of aromatic ring number in phenolic compound-conjugated chitosan injectables for sustained therapeutic antiglaucoma efficacy.
Topics: Animals; Chitosan; Drug Delivery Systems; Gelatin; Glaucoma; Humans; Hypertension; Inflammation; Kaempferols; Oxidative Stress; Phenols; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2020 |
Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: polyethylene glycol versus chitosan oligosaccharide lactate.
Topics: Administration, Oral; Caco-2 Cells; Chitosan; Humans; Hypertension; Nanoparticles; Nebivolol; Oligosaccharides; Polyethylene Glycols | 2016 |
Observational study of the effect of substituting NaCl with NaCl+Chitosan 3% (Symbiosal®) in the diet of elderly subjects on their blood pressure values.
Topics: Aged; Aged, 80 and over; Blood Pressure; Chitosan; Female; Follow-Up Studies; Humans; Hypertension; Male; Sodium Chloride, Dietary | 2015 |
Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.
Topics: Adjuvants, Pharmaceutic; Administration, Cutaneous; Animals; Antihypertensive Agents; Calorimetry, Differential Scanning; Carbazoles; Carvedilol; Chitosan; Cholesterol; Delayed-Action Preparations; Desoxycorticosterone; Drug Delivery Systems; Drug Synergism; Epidermis; Female; Glycyrrhizic Acid; Hypertension; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Permeability; Propanolamines; Rats; Rats, Wistar; Skin Absorption; Solubility; Sphingosine; Surface-Active Agents; Triglycerides | 2008 |
Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Asparagus Plant; Blood Pressure; Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Desoxycorticosterone; Disease Models, Animal; Drug Compounding; Epidermis; Female; Hypertension; Male; Permeability; Plant Extracts; Plant Roots; Propanolamines; Rats; Rats, Wistar; Saponins; Skin Absorption; Sphingosine; Technology, Pharmaceutical; Time Factors; Triglycerides | 2009 |
NaCl plus chitosan as a dietary salt to prevent the development of hypertension in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Chitosan; Chlorides; Creatinine; Heart; Histocytochemistry; Hypertension; Kidney; Male; Potassium; Potassium Chloride; Random Allocation; Rats; Rats, Inbred SHR; Sodium; Sodium Chloride, Dietary; Systole | 2009 |
Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Desoxycorticosterone; Disease Models, Animal; Epidermis; Excipients; Female; Glycine max; Hypertension; Male; Permeability; Plant Extracts; Propanolamines; Rats; Rats, Wistar; Skin Absorption; Solubility | 2009 |
Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension.
Topics: Acrylic Resins; Adhesiveness; Administration, Buccal; Animals; Antihypertensive Agents; Biological Availability; Carboxymethylcellulose Sodium; Chitosan; Diffusion; Dosage Forms; Drug Carriers; Drug Delivery Systems; Drug Stability; Excipients; Hydrogen-Ion Concentration; Hypertension; Mouth Mucosa; Nimodipine; Pharmaceutical Preparations; Rabbits; Solubility; Technology, Pharmaceutical; Viscosity | 2010 |
[The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases].
Topics: Anticholesteremic Agents; Blood Coagulation Factors; Blood Glucose; Cardiovascular Diseases; Chitosan; Data Interpretation, Statistical; Humans; Hyperlipoproteinemias; Hypertension; Lipids; Myocardial Ischemia; Time Factors; Treatment Outcome | 2005 |
Chitosan potentiation of warfarin effect.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chitosan; Chronic Disease; Diabetes Mellitus, Type 2; Drug Synergism; Humans; Hypertension; International Normalized Ratio; Male; Self Medication; Thrombosis; Vitamin K; Vitamins; Warfarin | 2007 |